Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1339165
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1339165
Branded Generics Market Share, Size, Trends, Industry Analysis Report, By Drug Class ; By Application; By Route of Administration; By Distribution Channel; By Region, And Segment Forecasts, 2023 - 2032
PUBLISHED:
PAGES: 117 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global branded generics market size is expected to reach USD 410.86 billion by 2032, according to a new study by Polaris Market Research. The report "Branded Generics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Alkylating Agents, Antimetabolites, Anti-Hypertensive); By Application; By Route of Administration; By Distribution Channel; By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Increasing rates of chronic diseases such as diabetes, hypertension, and cancer are driving the demand for drugs. Branded generics are becoming a popular choice for patients suffering from chronic illnesses as they offer a more affordable alternative to expensive brand-name drugs. The widespread use of generic drugs is another factor driving the branded generics market.
Generic drugs have become more widely accepted by both physicians and patients as they are equivalent in quality, safety, and efficacy to their brand-name counterparts. Government initiatives promoting the use of generic drugs to reduce overall healthcare costs are also driving the growth of the branded generics market. Governments worldwide are promoting the use of generic drugs to lower healthcare costs and increase access to affordable medicines for patients.
Growing burden of infectious and non-infectious diseases, along with the rising geriatric population, is expected to have a positive impact on the healthcare industry's growth. Chronic diseases such as diabetes, hypertension, and obesity are becoming more prevalent worldwide, and the geriatric population is more susceptible to these diseases.
As a result, the demand for healthcare services and products, including branded generics, is expected to increase significantly. According to an NCBI article, there were 537 million patients suffering from diabetes globally in 2021. Diabetes is a chronic disease that requires ongoing medical care and management. Branded generics are becoming a popular choice for diabetic patients as they offer a more affordable alternative to expensive brand-name drugs.
Hypertension is another chronic disease that is prevalent among the geriatric population. According to the World Health Organization (WHO), hypertension impacts 1 Bn people globally, and this is expected to rise to 1.5 Bn, by 2025. Branded generics offer an affordable treatment option for hypertension, which is driving their demand in the market.
Branded Generics Market Report Highlights
Anti-hypersensitive segment accounted for the largest share, owing to rise in cardiac ailments among geriatrics, and availability of low-cost alternatives
Oral segment accounted for the larger market share, owing to the advantages of oral based drug administration with minimal nursing experience, with high accept patient acceptability
Retail pharmacy is projected to experience larger revenue share, primarily due to increase in number of retail pharmacies in the developed markets
APAC is projected to register a higher growth rate in the study period, due to increase in preference of low-cost medicines
The global players include: Teva Pharmaceutical, Lupin, Sanofi, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Endo International, GlaxoSmithKline, Pfizer, Apotex, and Viatris, Inc.
Polaris Market Research has segmented the branded generics market report based on drug class, application, route of administration, by distribution channel, and region:
Branded Generics, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-Hypertensive
- Lipid Lowering Drugs
- Anti-Depressants
- Anti-Psychotics
- Anti-Epileptics
- Others
Branded Generics, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological Diseases
- Acute and Chronic Pain
- Others
Branded Generics, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)
- Topical
- Oral
- Parenteral
- Others
Branded Generics, Distribution Channel Industry Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Branded Generics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM3545
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Distribution Channels
- 3.2.1. Primary Distribution Channels
- 3.2.2. Secondary Distribution Channels
4. Global Branded Generics Market Insights
- 4.1. Branded Generics Market - Distribution Channel Snapshot
- 4.2. Branded Generics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing prevalence rate of chronic diseases
- 4.2.1.2. Rising number of expired patents
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Strict regulatory policies and huge competition from branded drugs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Branded Generics Market Distribution Channel Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Branded Generics Market, by Drug Class
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 5.3. Alkylating Agents
- 5.3.1. Global Branded Generics Market, by Alkylating Agents, by Region, 2019-2032 (USD Billion)
- 5.4. Antimetabolites
- 5.4.1. Global Branded Generics Market, by Antimetabolites, by Region, 2019-2032 (USD Billion)
- 5.5. Hormones
- 5.5.1. Global Branded Generics Market, by Hormones, by Region, 2019-2032 (USD Billion)
- 5.6. Anti-Hypertensive
- 5.6.1. Global Branded Generics Market, by Anti-Hypertensive, by Region, 2019-2032 (USD Billion)
- 5.7. Lipid Lowering Drugs
- 5.7.1. Global Branded Generics Market, by Lipid Lowering Drugs, by Region, 2019-2032 (USD Billion)
- 5.8. Anti-Depressants
- 5.8.1. Global Branded Generics Market, by Anti-Depressants, by Region, 2019-2032 (USD Billion)
- 5.9. Anti-Psychotics
- 5.9.1. Global Branded Generics Market, by Anti-Psychotics, by Region, 2019-2032 (USD Billion)
- 5.10. Anti-Epileptics
- 5.10.1. Global Branded Generics Market, by Anti-Epileptics, by Region, 2019-2032 (USD Billion)
- 5.11. Others
- 5.11.1. Global Branded Generics Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Branded Generics Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 6.3. Oncology
- 6.3.1. Global Branded Generics Market, by Oncology, by Region, 2019-2032 (USD Billion)
- 6.4. Cardiovascular Diseases
- 6.4.1. Global Branded Generics Market, by Cardiovascular Diseases, by Region, 2019-2032 (USD Billion)
- 6.5. Neurological Diseases
- 6.5.1. Global Branded Generics Market, by Neurological Diseases, by Region, 2019-2032 (USD Billion)
- 6.6. Gastrointestinal Diseases
- 6.6.1. Global Branded Generics Market, by Gastrointestinal Diseases, by Region, 2019-2032 (USD Billion)
- 6.8. Dermatological Diseases
- 6.8.1. Global Branded Generics Market, by Dermatological Diseases, by Region, 2019-2032 (USD Billion)
- 6.9. Acute and Chronic Pain
- 6.9.1. Global Branded Generics Market, by Acute and Chronic Pain, by Region, 2019-2032 (USD Billion)
- 6.10. Others
- 6.10.1. Global Branded Generics Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Branded Generics Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 7.3. Topical
- 7.3.1. Global Branded Generics Market, by Topical, By Region, 2019-2032 (USD Billion)
- 7.4. Oral
- 7.4.1. Global Branded Generics Market, by Oral, By Region, 2019-2032 (USD Billion)
- 7.5. Parenteral
- 7.5.1. Global Branded Generics Market, by Parenteral, By Region, 2019-2032 (USD Billion)
- 7.6. Oral
- 7.6.1. Global Branded Generics Market, by Oral, By Region, 2019-2032 (USD Billion)
8. Global Branded Generics Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Branded Generics Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Branded Generics Market - North America
- 8.3.1. North America: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.3.2. North America: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.3. North America: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.3.4. Branded Generics Market - U.S.
- 8.3.4.1. U.S.: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.3.5. Branded Generics Market - Canada
- 8.3.5.1. Canada: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.4. Branded Generics Market - Europe
- 8.4.1. Europe: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.3. Europe: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.4.4. Branded Generics Market - UK
- 8.4.4.1. UK: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.4.5. Branded Generics Market - France
- 8.4.5.1. France: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.5.3. France: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.4.6. Branded Generics Market - Germany
- 8.4.6.1. Germany: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.4.7. Branded Generics Market - Italy
- 8.4.7.1. Italy: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.4.8. Branded Generics Market - Spain
- 8.4.8.1. Spain: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.4.9. Branded Generics Market - Netherlands
- 8.4.9.1. Netherlands: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.4.10. Branded Generics Market - Russia
- 8.4.10.1. Russia: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.5. Branded Generics Market - Asia Pacific
- 8.5.1. Asia Pacific: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.5.4. Branded Generics Market - China
- 8.5.4.1. China: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.4.3. China: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.5.5. Branded Generics Market - India
- 8.5.5.1. India: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.5.3. India: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.5.6. Branded Generics Market - Malaysia
- 8.5.6.1. Malaysia: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.5.7. Branded Generics Market - Japan
- 8.5.7.1. Japan: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.5.8. Branded Generics Market - Indonesia
- 8.5.8.1. Indonesia: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.5.9. Branded Generics Market - South Korea
- 8.5.9.1. South Korea: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.6. Branded Generics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.6.4. Branded Generics Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.6.5. Branded Generics Market - UAE
- 8.6.5.1. UAE: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.6.6. Branded Generics Market - Israel
- 8.6.6.1. Israel: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.6.7. Branded Generics Market - South Africa
- 8.6.7.1. South Africa: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.7. Branded Generics Market - Latin America
- 8.7.1. Latin America: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.7.4. Branded Generics Market - Mexico
- 8.7.4.1. Mexico: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.7.5. Branded Generics Market - Brazil
- 8.7.5.1. Brazil: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- 8.7.6. Branded Generics Market - Argentina
- 8.7.6.1. Argentina: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Branded Generics Market, by Application, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Teva Pharmaceutical
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Drug Class Benchmarking
- 10.1.4. Recent Development
- 10.2. Lupin
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Drug Class Benchmarking
- 10.2.4. Recent Development
- 10.3. Sanofi
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Drug Class Benchmarking
- 10.3.4. Recent Development
- 10.4. Sun Pharmaceutical Industries
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Drug Class Benchmarking
- 10.4.4. Recent Development
- 10.5. Dr. Reddy's Laboratories
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Drug Class Benchmarking
- 10.5.4. Recent Development
- 10.6. Endo International
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Drug Class Benchmarking
- 10.6.4. Recent Development
- 10.7. GlaxoSmithKline
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Drug Class Benchmarking
- 10.7.4. Recent Development
- 10.8. Pfizer
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Drug Class Benchmarking
- 10.8.4. Recent Development
- 10.9. Apotex
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Drug Class Benchmarking
- 10.9.4. Recent Development
- 10.10. Viatris, Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Drug Class Benchmarking
- 10.10.4. Recent Development
Product Code: PM3545
List of Tables
- Table 1 Global Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 2 Global Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 3 Global Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 4 Branded Generics Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 5 North America: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 6 North America: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 7 North America: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 8 U.S.: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 9 U.S.: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 10 U.S.: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 11 Canada: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 12 Canada: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 13 Canada: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 14 Europe: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 15 Europe: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 16 Europe: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 17 UK: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 18 UK: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 19 UK: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 20 France: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 21 France: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 22 France: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 23 Germany: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 24 Germany: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 25 Germany: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 26 Italy: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 27 Italy: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 28 Italy: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 29 Spain: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 30 Spain: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 31 Spain: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 32 Netherlands: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 33 Netherlands: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 34 Netherlands: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 35 Russia: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 36 Russia: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 37 Russia: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 38 Asia Pacific: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 39 Asia Pacific: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 40 Asia Pacific: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 41 China: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 42 China: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 43 China: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 44 India: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 45 India: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 46 India: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 47 Malaysia: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 48 Malaysia: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 49 Malaysia: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 50 Japan: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 51 Japan: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 52 Japan: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 53 Indonesia: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 54 Indonesia: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 55 Indonesia: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 56 South Korea: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 57 South Korea: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 58 South Korea: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 59 Middle East & Africa: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 60 Middle East & Africa: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 61 Middle East & Africa: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 62 Saudi Arabia: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 63 Saudi Arabia: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 64 Saudi Arabia: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 65 UAE: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 66 UAE: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 67 UAE: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 68 Israel: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 69 Israel: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 70 Israel: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 71 South Africa: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 72 South Africa: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 73 South Africa: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 74 Latin America: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 75 Latin America: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 76 Latin America: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 77 Mexico: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 78 Mexico: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 79 Mexico: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 80 Brazil: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 81 Brazil: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 82 Brazil: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 83 Argentina: Branded Generics Market, by Drug Class, 2019-2032 (USD Billion)
- Table 84 Argentina: Branded Generics Market, by Application, 2019-2032 (USD Billion)
- Table 85 Argentina: Branded Generics Market, by Distribution Channel, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Branded Generics Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Application
- Figure 7. Global Branded Generics Market, by Application, 2022 & 2032 (USD Billion)
- Figure 8. Market by Drug Class
- Figure 9. Global Branded Generics Market, by Drug Class, 2022 & 2032 (USD Billion)
- Figure 10. Market by Distribution Channel
- Figure 11. Global Branded Generics Market, by Distribution Channel, 2022 & 2032 (USD Billion)
- Figure 12. Branded Generics Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 13. Strategic Analysis - Branded Generics Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.